Our team values clear communication between sponsors and our scientists, project managers, lab staff, etc. Could you please provide us additional introductory and background information about your therapeutic(s), target(s), preferred critical reagents, ADA and nAb assay supplies, previous immunogenicity analysis data from experimental run(s), ADA study protocols (with # of cohorts, ADA samples), and any crucial ADA Analysis or nAb analysis assay needs? All this information will help us accurately and efficiently define the scope of work for quotation and timeline estimation.